These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25834393)

  • 1. Clinicopathological significance of CXCR4 in non-small cell lung cancer.
    Zhou XM; He L; Hou G; Jiang B; Wang YH; Zhao L
    Drug Des Devel Ther; 2015; 9():1349-58. PubMed ID: 25834393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
    Zhang C; Li J; Han Y; Jiang J
    Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
    Wang Z; Wang B; Guo H; Shi G; Hong X
    Drug Des Devel Ther; 2015; 9():207-16. PubMed ID: 25565774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.
    Xu L; Lan H; Su Y; Li J; Wan J
    Drug Des Devel Ther; 2015; 9():2855-65. PubMed ID: 26082616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of CXCR4 expression in renal cell carcinoma: a meta-analysis.
    Tang B; Tang F; Li Y; Yuan S; Li B; Wang Z; He S
    Ann Surg Oncol; 2015 Mar; 22(3):1026-31. PubMed ID: 25249257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis.
    Wang H; Xie F; Hu Z; Chen L
    Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review.
    Wu X; Wu G; Yao X; Hou G; Jiang F
    Drug Des Devel Ther; 2016; 10():699-709. PubMed ID: 26929601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review.
    Yan W; Xu N; Han X; Zhou XM; He B
    Sci Rep; 2016 Jan; 6():19303. PubMed ID: 26796853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.
    Fung AS; Kopciuk K; Dean ML; D'Silva A; Otsuka S; Klimowicz A; Hao D; Morris D; Bebb DG
    PLoS One; 2021; 16(1):e0241240. PubMed ID: 33507926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
    Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
    J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].
    Hu T; Yao Y; Yu S; Guo H; Tian T; Han L; Wang W; Guo Q; Wang J; Nan K; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):153-8. PubMed ID: 24589587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.
    Reckamp KL; Figlin RA; Burdick MD; Dubinett SM; Elashoff RM; Strieter RM
    BMC Cancer; 2009 Jun; 9():213. PubMed ID: 19563666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of adhesion molecule CEACAM1 and chemokine receptor CXCR4 expression on prognosis of non-small cell lung cancer patients].
    Yurdakul AS; Akyürek N; Demirtaş S; Karakaya J; Memiş L; Oztürk C
    Tuberk Toraks; 2010; 58(4):351-6. PubMed ID: 21341111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases.
    Paratore S; Banna GL; D'Arrigo M; Saita S; Iemmolo R; Lucenti L; Bellia D; Lipari H; Buscarino C; Cunsolo R; Cavallaro S
    Cancer Biomark; 2011-2012; 10(2):79-89. PubMed ID: 22430135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S; Qiu Z; He J; Li L; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer.
    Al Zobair AA; Al Obeidy BF; Yang L; Yang C; Hui Y; Yu H; Zheng F; Yang G; Xie C; Zhou F; Zhou Y
    Oncol Rep; 2013 Apr; 29(4):1524-32. PubMed ID: 23443279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
    Qiu L; Xu Y; Xu H; Yu B
    BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
    Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
    Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.
    Chen Q; Zhong T
    Drug Des Devel Ther; 2015; 9():5115-22. PubMed ID: 26379424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.